Get started
Author

Amr Emara

Observed names: A Emara, A. Emara, A.M. Emara, Amr M. Emara
Observed institutions: Ain Shams University, Royal Surrey County Hospital, Frimley Park Hospital, Hampshire Hospitals NHS Foundation Trust, Basingstoke and North Hampshire Hospital, Ain Shams University Hospital
ORCID: 0000-0001-5619-261X
Observed ORCID: 0000-0001-5619-261X
OpenAlex ID: A5023241158
Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience
2022 · Deepika Reddy, Max Peters, et al. · European Urology · 141
PDF
Real-world Early Outcomes and Retreatment Rates Following Water Vapour Ablative Therapy for Symptomatic Benign Prostatic Hyperplasia
2022 · Danielle Whiting, Mohamed Noureldin, et al. · European Urology Open Science · 37
PDF
Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysis
2023 · Deepika Reddy, Marieke van Son, et al. · Journal of Medical Economics · 23
Magnetic Resonance Imaging and Targeted Biopsies Compared to Transperineal Mapping Biopsies Before Focal Ablation in Localised and Metastatic Recurrent Prostate Cancer After Radiotherapy
2022 · Taimur T. Shah, Abi Kanthabalan, et al. · European Urology · 22
Oncological Outcomes Following Focal HIFU and Cryotherapy for Treatment of Nonmetastatic Prostate Cancer in the United Kingdom: An Updated Analysis of 3477 Patients from the Prospective HEAT and ICE Registries
2026 · Alexander Light, Max Peters, et al. · European Urology · 11
PDF
Evaluation of Outcomes Following Focal Ablative Therapy for Treatment of Localized Clinically Significant Prostate Cancer in Patients >70 Years: A Multi-institute, Multi-energy 15-Year Experience
2023 · David Habashy, Deepika Reddy, et al. · The Journal of Urology · 10
PDF
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial
2025 · Gianmarco Leone, Francesco Orlando, et al. · JAMA Oncology · 9
Water vapor thermotherapy and high-grade Clavien-Dindo complications: retrospective analysis of 10 cases
2026 · Luca Cindolo, Antonio Minore, et al. · World Journal of Urology · 4
Mp01-03 Rezūm Water Vapour Ablation Therapy for Benign Prostatic Hyperplasia: Initial Results From the United Kingdom
2019 · Maximilian Johnston*, Taimur Shah, et al. · The Journal of Urology · 4
External validation of a risk model predicting failure of salvage focal ablation for prostate cancer
2023 · Alexander Light, Max Peters, et al. · British Journal of Urology · 3
PDF
Ip37-01 10-year Oncological Outcomes Following Focal Hifu and Cryotherapy for Treatment of Non-metastatic Prostate Cancer: an Analysis of 3471 Patients From the Prospective Heat and Ice Registries
2026 · Alexander Light, Max Peters, et al. · The Journal of Urology · 2
PDF
Mp70-11 Medium Term Outcomes Following Focal Hifu for the Treatment of Localised Prostate Cancer: a Single Centre Experience.
2017 · Kiki Mistry, Utsav Reddy, et al. · The Journal of Urology · 2
Mp42-16 Assessment of Energy Density Usage During 180w Lithium Triborate Laser Photo-selective Vaporization of the Prostate for Benign Prostatic Hyperplasia. Is There an Optimal Amount of Kilo-joules Per Gram of Prostate?
2016 · Roger Valdivieso, Christian Meyer, et al. · The Journal of Urology · 1
PDF
Ip26-09 Validation of Existing Risk Stratification Tools for Predicting Treatment Failure After Focal Therapy: an Analysis of 3460 Patients From the Heat and Ice Registries
2026 · Alexander Light, Max Peters, et al. · The Journal of Urology
PDF
Ip53-04 the Added Value of Diffusion-weighted Imaging and Dynamic Contrast-enhanced Sequences in the Diagnosis of Localized Radiorecurrent Prostate Cancer: an Analysis From the Forecast Trial
2026 · Alexander Light, Abi Kanthabalan, et al. · The Journal of Urology
Ip37-02 Comparison of Contemporary Patient Selection Criteria for Focal Therapy: an Analysis of 2658 Patients From the Prospective Heat and Ice Registries
2026 · Alexander Light, Max Peters, et al. · The Journal of Urology
PDF
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy can be safely combined with nephrectomy in patients with appendiceal malignancy and synchronous renal cell carcinoma
2026 · Siu Y Kok, Faheez Mohamed, et al. · Journal of Surgical Case Reports
Focal HIFU and cryotherapy for prostate cancer: A HEAT and ICE analysis of 15-year usage trends in the United Kingdom
2024 · A. Light, N. Mayor, et al. · European Urology
372 Is the Mixing of Local Anaesthetic Agents for Perineal Block in TP Prostate Biopsy Patients Advantageous? a Comparative Study of Local Anaesthetic Efficacy
2023 · K Bhopal, O A Allat, et al. · British journal of surgery
PDF
Mp73-04 External Validation of a Risk Score Predicting Failure After Salvage Focal Therapy for Localized Radiorecurrent Prostate Cancer: an Analysis From the Focal Recurrent Assessment and Salvage Treatment (forecast) Trial
2023 · Alexander Light, Max Peters, et al. · The Journal of Urology
Mp44-06 Tumor Characteristics of Multiparametric Mri-detected and -undetected Lesions in Patients With Suspected Radiorecurrent Prostate Cancer: an Analysis From the Focal Recurrent Assessment and Salvage Treatment (forecast) Trial
2023 · Alexander Light, Abi Kanthabalan, et al. · The Journal of Urology
PDF
Mp44-02 Systematic and Mri-targeted Biopsy Strategies for the Detection of Radiorecurrent Prostate Cancer: an Analysis From the Focal Recurrent Assessment and Salvage Treatment (forecast) Trial
2023 · Alexander Light, Abi Kanthabalan, et al. · The Journal of Urology
PDF
Corrigendum to “Magnetic Resonance Imaging and targeted biopsies compared to transperineal mapping biopsies prior to salvage focal therapy/ablation in localised and metastatic recurrent prostate cancer after radiotherapy. Primary Outcomes from the FORECAST Trial” [Eur Urol 2022;81(6):598–605]
2023 · Taimur T. Shah, Abi Kanthabalan, et al. · European Urology
Mp55-06 Focal Ablative Salvage Therapy for Radio-recurrent Prostate Cancer: 6 Year Oncological and Safety Outcomes
2022 · Deepika Reddy, Max Peters, et al. · The Journal of Urology
Mp55-01 Cancer Control Outcomes Following Focal Therapy Using Hifu in 1,379 Men With Non-metastatic Prostate Cancer: a Multi-institute 15-year Experience
2022 · Deepika Reddy, Max Peters, et al. · The Journal of Urology
Works count: 38
Citation count: 269
H-index: 7
I10-index: 6
Year
Topic
Type